Morbidity and mortality in medium chain acyl coenzyme A dehydrogenase deficiency.
about
Efficacy and outcome of expanded newborn screening for metabolic diseases--report of 10 years from South-West GermanyProtein misfolding is the molecular mechanism underlying MCADD identified in newborn screeningEvaluation of newborn screening for medium chain acyl-CoA dehydrogenase deficiency in 275 000 babiesCost-effectiveness analysis of universal newborn screening for medium chain acyl-CoA dehydrogenase deficiency in France.The domain-specific and temperature-dependent protein misfolding phenotype of variant medium-chain acyl-CoA dehydrogenaseImpaired fasting tolerance among Alaska native children with a common carnitine palmitoyltransferase 1A sequence variantNewborn screening for medium chain acyl-CoA dehydrogenase deficiency in England: prevalence, predictive value and test validity based on 1.5 million screened babiesMedium-chain acyl-CoA dehydrogenase deficiency associated with a novel splice mutation in the ACADM gene missed by newborn screening.Medium-Chain Acyl-CoA Dehydrogenase Deficiency: Evaluation of Genotype-Phenotype Correlation in Patients Detected by Newborn ScreeningDecision analysis, economic evaluation, and newborn screening: challenges and opportunities.Incidence of medium-chain acyl-CoA dehydrogenase deficiency in Canada using the Canadian Paediatric Surveillance Program: Role of newborn screening.The epidemiology of medium chain acyl-CoA dehydrogenase deficiency: an update.221 newborn-screened neonates with medium-chain acyl-coenzyme A dehydrogenase deficiency: Findings from the Inborn Errors of Metabolism Collaborative.Morbidity and mortality among exclusively breastfed neonates with medium-chain acyl-CoA dehydrogenase deficiency.Prospective surveillance study of medium chain acyl-CoA dehydrogenase deficiency in the UK.Biochemical characterization of a variant human medium-chain acyl-CoA dehydrogenase with a disease-associated mutation localized in the active site.Outcome of medium chain acyl-CoA dehydrogenase deficiency after diagnosis.Ethnicity of children with homozygous c.985A>G medium-chain acyl-CoA dehydrogenase deficiency: findings from screening approximately 1.1 million newborn infants.Oxidative stress induction by cis-4-decenoic acid: relevance for MCAD deficiency.Neuropsychological functioning in children with medium chain acyl coenzyme a dehydrogenase deficiency (MCADD): the impact of early diagnosis and screening on outcome.Medium-chain acyl-CoA dehydrogenase deficiency: Two novel ACADM mutations identified in a retrospective screening.
P2860
Q21202867-38610A19-6915-451C-AFC5-42BCCEE8277AQ24312099-CEB75ACE-35B6-4DD4-802D-5AEE66810A82Q28346551-FABFD707-DC18-413B-86E7-685890FBD557Q34297808-A2EC31EF-9C68-4E29-8AF7-FE28DADAC2E4Q35144068-0959A69C-3234-4B04-B8D4-00438C15B841Q35400586-D02EC702-54C5-42B9-BC5D-27074695D636Q35626478-BBE6ACAD-8EEF-4E27-B03F-FAEFD617F8B5Q35724819-B7191EF6-6E50-46E6-8352-781F814DB2CCQ35795433-7B034D56-BEFF-416D-8A2F-3181AEEE7F7CQ35799904-9924DD8D-AF44-4D94-8F73-732649BE5624Q36054005-6F077422-76B9-4819-9F57-E47A2FDB321AQ36450404-9ABCE272-B5D2-43ED-8C7B-AF6D6CB59448Q39539724-0BBBB985-7D8A-4F3D-9C0C-F066F3A28536Q41201972-71F9764D-EFAA-4465-AD32-DB9CC2BFC360Q42083993-7A41F4D9-DC38-430F-A5DF-CB8B0AA1D855Q42992488-82DD1C65-EBE6-460E-862F-4C9D261255AAQ43102350-19A16629-4E32-4D5B-B755-208BD54C26B9Q46312678-AD19975B-F51D-4D12-9474-D70E5425B346Q46911407-7D4DAE4A-37D1-4C1D-8C95-9FF2BB713067Q49111246-CF8691BB-656D-4FFF-92F6-B775B75D55C1Q49927469-B22FFFDD-74D3-4554-9503-49507B2D5C58
P2860
Morbidity and mortality in medium chain acyl coenzyme A dehydrogenase deficiency.
description
1994 nî lūn-bûn
@nan
1994 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Morbidity and mortality in medium chain acyl coenzyme A dehydrogenase deficiency.
@ast
Morbidity and mortality in medium chain acyl coenzyme A dehydrogenase deficiency.
@en
Morbidity and mortality in medium chain acyl coenzyme A dehydrogenase deficiency.
@nl
type
label
Morbidity and mortality in medium chain acyl coenzyme A dehydrogenase deficiency.
@ast
Morbidity and mortality in medium chain acyl coenzyme A dehydrogenase deficiency.
@en
Morbidity and mortality in medium chain acyl coenzyme A dehydrogenase deficiency.
@nl
prefLabel
Morbidity and mortality in medium chain acyl coenzyme A dehydrogenase deficiency.
@ast
Morbidity and mortality in medium chain acyl coenzyme A dehydrogenase deficiency.
@en
Morbidity and mortality in medium chain acyl coenzyme A dehydrogenase deficiency.
@nl
P2093
P2860
P356
P1476
Morbidity and mortality in medium chain acyl coenzyme A dehydrogenase deficiency.
@en
P2093
P2860
P304
P356
10.1136/ADC.70.5.410
P407
P577
1994-05-01T00:00:00Z